Doctor of Medicine, Chief Physician, Professor, Doctoral Supervisor, and Deputy Director of the Department of Urologic Oncology Surgery; Distinguished Talent of the Beijing Hospital Authority. Specialties: Minimally invasive urologic oncology surgeries and Da Vinci robotic surgeries, including laparoscopic radical nephrectomy, laparoscopic partial nephrectomy, laparoscopic radical prostatectomy, laparoscopic retroperitoneal lymph node dissection, laparoscopic radical cystectomy, and laparoscopic inguinal lymph node dissection. Dedicated to researching the molecular pathogenesis and precision treatment of urologic tumors. From December 2010 to November 2011, served as a visiting scholar at the School of Medicine, Cardiff University, UK, conducting basic research on the occurrence and metastasis of urologic tumors. From June 2013 to September 2013, served as a visiting scholar in the Department of Urology at the University of Rochester Medical Center, USA, studying robot-assisted and other laparoscopic minimally invasive urologic surgeries. Currently serves as Executive Director of the Beijing Anti-Cancer Association, Chair of the Early Cancer Screening Committee of the Beijing Anti-Cancer Association, Member of the Robotics Group of the Urology Branch of the Chinese Medical Doctor Association, Member of the Robotics Group of the Urology Branch of the Beijing Medical Association, and Executive Editor-in-Chief of the *Journal of Urology* (Electronic Edition). Has led multiple national and provincial-level research projects and published over 60 SCI papers as first author or corresponding author.